Vitamin D and autoimmune thyroid diseases

Cellular and Molecular Immunology

Volumn 8, Issue 3, 2011, Pages 243-247

  Kivity, Shaye ^a,b   Agmon Levin, Nancy ^a,b   Zisappl, Michael ^a   Shapira, Yinon ^a   Nagy, Endre V ^c   Dankó, Katalin ^c   Szekanecz, Zoltan ^c   Langevitz, Pnina ^b   Shoenfeld, Yehuda ^a,b  

^a TEL AVIV UNIVERSITY   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

^c UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

autoantibodies; autoimmune thyroid disease; Graves' disease; Hashimoto's thyroiditis; vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; THYROID ANTIBODY; VITAMIN D;

ADULT; ARTICLE; AUTOIMMUNE THYROIDITIS; CHEMOLUMINESCENCE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; IMMUNOASSAY; IMMUNOPATHOGENESIS; MALE; THYROID FUNCTION TEST; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

ADULT; AUTOANTIBODIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; THYROID FUNCTION TESTS; THYROID GLAND; THYROIDITIS, AUTOIMMUNE; THYROTROPIN; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 79955661359     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2010.73     Document Type: Article

References (53)

1. Zittermann A, Schleithoff SS, Koerfer R. Putting cardiovascular disease and vitamin D insufficiency into perspective. Br J Nutr 2005; 94: 483-492. (Pubitemid 41555486)
2. Giovannucci E, Liu Y, Rimm EB, Hollis BW, Fuchs CS, Stampfer MJ et al. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst 2006; 98: 451-459.
3. Shapira Y, Agmon-Levin N, Shoenfeld Y. Mycobacteriumtuberculosis, autoimmunity, and vitamin D. Clin Rev Allergy Immunol 2009; 39: 3147-3159.
4. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008; 117: 503-511.
5. Giovannucci E. Epidemiological evidenceforvitamin Dand colorectal cancer. J Bone Miner Res 2007; 22Suppl 2: V81-V85. (Pubitemid 351304655)
6. Hypponen E, Laara E, Reunanen A, Jarvelin MR, Virtanen SM. Intakeofvitamin Dand risk of type 1 diabetes: a birth-cohort study. Lancet 2001; 358: 1500-1503. (Pubitemid 33055701)
7. Merlino LA, Curtis J, Mikuls TR, Cerhan JR, Criswell LA, Saag KG. Vitamin D intake is inverselyassociated with rheumatoid arthritis: resultsfromthe Iowa Women's Health Study. Arthritis Rheum 2004; 50: 72-77. (Pubitemid 38084289)
8. Huisman AM, White KP, Algra A, Harth M, Vieth R, Jacobs JW et al. Vitamin D levelsin womenwith systemic lupuserythematosusand fibromyalgia. JRheumatol 2001; 28: 2535-2539. (Pubitemid 33031987)
9. Kamen DL, Cooper GS, Bouali H, Shaftman SR, Hollis BW, Gilkeson GS. Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev 2006; 5: 114-117. (Pubitemid 43129539)
10. Ben-Zvi I, Aranow C, Mackay M, Stanevsky A, Kamen DL, Marinescu LM et al. The impact of vitamin D on dendritic cell function in patients with systemic lupus erythematosus. PLoS One 2010; 5: e 9193.
11. Shapira Y, Agmon-Levin N, Shoenfeld Y. Geoepidemiology of autoimmune diseases. Autoimmunity 2010; 8: 468-476.
12. Shoenfeld N, Amital H, Shoenfeld Y. Theeffect of melanism and vitamin Dsynthesis ontheincidenceof autoimmunedisease. Nat Clin Pract Rheumatol 2009; 5: 99-105
13. Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors. Ann Neurol 2007; 61: 504-513. (Pubitemid 47068132)
14. Dahlquist G, Mustonen L. Childhood onset diabetes\timetrends and climatological factors. Int J Epidemiol 1994; 23: 1234-1241.
15. The EURODIAB Substudy 2 Study Group. Vitamin D supplement in early childhood and risk for Type I (insulin-dependent)diabetesmellitus. Diabetologia 1999; 42: 51-54.
16. 3 prevents insulitis in NOD mice. Diabetes 1992; 41: 1491-1495.
17. 3 in rheumatoid arthritis patients. Clin Exp Rheumatol 1999; 17: 453-456. (Pubitemid 29343630)
18. Myhr KM. Vitamin D treatment in multiple sclerosis. J Neurol Sci 2009; 286: 104-108.
19. Munger KL, Zhang SM, O'Reilly E, Hernán MA, Olek MJ, Willett WC et al. Vitamin D intake and incidence of multiplesclerosis. Neurology 2004; 62: 60-65.
20. 3: a pilot study. Arthritis Rheum 1990; 33: 1723-1727.
21. Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006; 296: 2832-2838. (Pubitemid 44969183)
22. Chen W, Lin H, Wang M. Immuneintervention effectson the induction of experimental autoimmunethyroiditis. J Huazhong Univ Sci Technolog Med Sci 2002; 22: 343-345, 354.
23. Misharin A, Hewison M, Chen CR, Lagishetty V, Aliesky HA, Mizutori Y et al. Vitamin D deficiencymodulatesGraves' hyperthyroidism induced in BALB/cmicebythyrotropin receptor immunization. Endocrinology 2009; 150: 1051-1060.
24. Orbach H, Shoenfeld Y. Vaccination infection and autoimmunity: myth and reality VIAMR 2005-10-26-28, Beau-Rivage Palace Hotel, Lausanne, Switzerland. Autoimmun Rev 2007; 6: 261-266. (Pubitemid 46507989)
25. 3 and intact parathyroid hormone in Graves' disease as compared to toxic nodular goiter. Calcif Tissue Int 1988; 42: 5-12. (Pubitemid 18053117)
26. Goswami R, Marwaha RK, Gupta N, Tandon N, Sreenivas V, Tomar N et al. Prevalence of vitamin D deficiency and its relationship with thyroid autoimmunity in Asian Indians:acommunity-basedsurvey. Br J Nutr 2009; 102:382-386.
27. Shoenfeld Y, Selmi C, Zimlichman E, Gershwin ME. The autoimmunologist: geoepidemiology, a new center of gravity, and prime time for autoimmunity. J Autoimmun 2008; 31: 325-330.
28. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med 2000; 160: 526-534. (Pubitemid 30112276)
29. Shoenfeld Y, Blank M, Abu-Shakra M, Amital H, Barzilai O, Berkun Y et al. Themosaic of autoimmunity: prediction, autoantibodies, and therapy in autoimmune diseases\2008. Isr Med Assoc J2008; 10: 13-19. (Pubitemid 351649456)
30. Shoenfeld Y, Gilburd B, Abu-Shakra M, Amital H, Barzilai O, Berkun Y et al. The mosaic of autoimmunity: genetic factors involved in autoimmune diseases\2008. Isr Med Assoc J2008; 10: 3-7. (Pubitemid 351649454)
31. Shoenfeld Y, Zandman-Goddard G, Stojanovich L, Cutolo M, Amital H, Levy Y et al. The mosaic of autoimmunity: hormonal and environmental factors involved in autoimmunediseases\2008. Isr Med Assoc J2008; 10: 8-12. (Pubitemid 351649455)
32. Tozzoli R, Barzilai O, Ram M, Villalta D, Bizzaro N, Sherer Y et al. Infections and autoimmune thyroid diseases: parallel detection of antibodies against pathogens with proteomic technology. Autoimmun Rev 2008; 8: 112-115.
33. Gershwin ME. The mosaic of autoimmunity. Autoimmun Rev 2008; 7: 161-163.
34. 3: basic concepts. J Steroid Biochem Mol Biol 2005; 97: 93-101.
35. Arnson Y, Amital H, Shoenfeld Y. Vitamin D and autoimmunity: newaetiological and therapeutic considerations. Ann Rheum Dis 2007; 66: 1137-1142.
36. Haussler MR, Whitfield GK, Haussler CA, Hsieh JC, Thompson PD, Selznick SH et al. The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res 1998; 13: 325-349. (Pubitemid 28146215)
37. Bikle DD, Gee E, Halloran B, Kowalski MA, Ryzen E, Haddad JG. Assessmentofthe free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein. J Clin Endocrinol Metab 1986; 63: 954-959. (Pubitemid 16004301)
38. Henry HL. Vitamin D hydroxylases. J Cell Biochem 1992; 49: 4-9.
39. 3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactiveT cell activation. JImmunol 2000; 164: 2405-2411. (Pubitemid 30115468)
40. 3. Diabetes 2002; 51: 2119-2125. (Pubitemid 34729016)
41. 4 T cells to enhance the development of Th2 cells. J Immunol 2001; 167: 4974-4980. (Pubitemid 33009728)
42. Lagunova Z, Porojnicu AC, Lindberg F, Hexeberg S, Moan J. The dependency of vitamin D status on body mass index, gender, age and season. Anticancer Res 2009; 29: 3713-3720.
43. Gomez-Alonso C, Naves-Diaz ML, Fernandez-Martin JL, Diaz-Lopez JB, Fernandez-Coto MT, Cannata-Andia JB. Vitamin D status and secondary hyperparathyroidism: the importanceof 25-hydroxyvitamin Dcut-off levels. Kidney Int Suppl 2003; (85): S44-S48. (Pubitemid 36605861)
44. 3 levels during management of thyrotoxicosis. Endocr Pract 2003;9:517-521.
45. Pani MA, Knapp M, Donner H, Braun J, Baur MP, Usadel KH et al. Vitamin D receptor allele combinations influence genetic susceptibility to type 1 diabetes in Germans. Diabetes 2000; 49: 504-507. (Pubitemid 30131799)
46. Pani MA, Seissler J, Usadel KH, Badenhoop K. Vitamin D receptor genotype is associatedwithAddison'sdisease. Eur JEndocrinol 2002; 147: 635-640.
47. Horst-Sikorska W, Ignaszak-Szczepaniak M, Marcinkowska M, Kaczmarek M, Stajgis M, Slomski R. Association analysis of vitamin D receptor gene polymorphisms with bone mineral density in young women with Graves' disease. Acta Biochim Pol 2008; 55: 371-380. (Pubitemid 351947552)
48. Stefanic M, Papic S, Suver M, Glavas-Obrovac L, Karner I. Association of vitamin D receptorgene3'-variantswith Hashimoto'sthyroiditisintheCroatianpopulation. Int J Immunogenet 2008; 35: 125-131.
49. Kurylowicz A, Ramos-Lopez E, Bednarczuk T, Badenhoop K. Vitamin D-binding protein (DBP) gene polymorphism is associated with Graves' disease and the vitamin D status in a Polish population study. Exp Clin Endocrinol Diabetes 2006; 114: 329-335. (Pubitemid 44166181)
50. Ban Y, Ban Y, Taniyama M, Katagiri T. Vitamin D receptor initiation codon polymorphism in Japanese patients with Graves' disease. Thyroid 2000; 10: 475-480. (Pubitemid 30437148)
51. Miller AE, Morgante LA, Buchwald LY, Nutile SM, Coyle PK, Krupp LB et al. A multicenter, randomized, double-blind, placebo-controlled trial of influenza immunization in multiple sclerosis. Neurology 1997; 48: 312-314. (Pubitemid 27087594)
52. Collins JE, Heward JM, Nithiyananthan R, Nejentsev S, Todd JA, Franklyn JA et al. Lack of association of the vitamin D receptor gene with Graves' disease in UK Caucasians. Clin Endocrinol (Oxf) 2004; 60: 618-624. (Pubitemid 38669853)
53. 3 deficiency. Bone 2009; 45: 747-749.